Author

P. Lavender

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Kelly· 2 shared A. Freeman· 1 shared A. Gallagher· 1 shared A. Iseppon· 1 shared A. Laurence· 1 shared A. Malik· 1 shared A. N. Akbar· 1 shared B. Afzali· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Kelly

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

T-bet fate mapping identifies a novel ILC1-ILC2 subset in vivo

J.-H. SCHROEDER, N. Garrido-Mesa, T. Zabinski, A. Gallagher, L. Campbell, L. Roberts, E. Stolarczyk, G. Beattie, J. Lo, A. Iseppon, C. Moreira Heliodoro, R. Reis, R. Jenner, P. Lavender, J. Howard, , G. Lord

The paper identifies a novel ILC1-ILC2 subset using T-bet fate mapping and shows its dependence on T-bet and cytokine expression capabilities.

bioRxiv · Aug 21, 2020 · PreprintImmunology

An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19

R. McGregor, D. Chauss, T. Freiwald, B. Yan, L. Wang, E. Nova-Lamperti, Z. Zhang, H. Teague, E. West, J. Bibby, A. Kelly, A. Malik, A. Freeman, D. Schwartz, D. Portilla, , B. Afzali

This study identifies a Vitamin D-driven mechanism that suppresses excessive Th1 responses in COVID-19, suggesting potential therapeutic use of Vitamin D analogs.

bioRxiv · Jul 18, 2020 · PreprintImmunology

GATA3 controls mitochondrial biogenesis in primary human CD4+ T cells during DNA damage

L. A. Callender, J. Schroth, E. C. Carroll, L. E. L. Romano, E. Hendy, A. Kelly, P. Lavender, A. N. Akbar, J. P. Chapple, S. M. Henson

This study identifies a novel mechanism by which GATA3 regulates mitochondrial biogenesis in primary human CD4+ T cells in response to DNA damage.

bioRxiv · May 15, 2020 · PreprintImmunology